HPV assay receives FDA approval

BD (Becton, Dickinson and Company), a leading global medical technology company, last week announced that it has received pre-market approval from the U.S. Food and Drug Administration (FDA) for the BD Onclaritya HPV assay. The test detects 14 types of high-risk human papillomavirus (HPV) from specimens collected for cervical cancer screening ("Pap test") in the BD ["]

The post HPV assay receives FDA approval appeared first on Outbreak News Today.